Terry Smith started to build up the position in Edwards Lifesciences in Q3 2022. Since then they sold 9.98 Thousand shares. The investor sold all their shares in Q2 2023 and doesn't own any shares in Edwards Lifesciences anymore.
NEW YORK , Sept. 29, 2021 /PRNewswire/ -- The potential central venous catheters market growth between 2021 and 2025 is USD 138.10 million . The market will ...
Benzinga, over 2 years agoDUBLIN, Jan. 8, 2021 /PRNewswire/ -- The "Central Venous Catheters (Drug Delivery Devices) - Global Market Analysis and Forecast Model (COVID-19 market impac...
PR Newswire, about 3 years ago